Blinatumomab retreatment after relapse in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia

M. S. Topp, M. Stelljes, G. Zugmaier, P. Barnette, L. T. Heffner, T. Trippett, J. Duell, R. C. Bargou, C. Holland, J. E. Benjamin, M. Klinger, Mark R Litzow

Research output: Contribution to journalLetter

11 Scopus citations
Original languageEnglish (US)
Pages (from-to)562-565
Number of pages4
JournalLeukemia
Volume32
Issue number2
DOIs
StatePublished - Feb 1 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Topp, M. S., Stelljes, M., Zugmaier, G., Barnette, P., Heffner, L. T., Trippett, T., Duell, J., Bargou, R. C., Holland, C., Benjamin, J. E., Klinger, M., & Litzow, M. R. (2018). Blinatumomab retreatment after relapse in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia. Leukemia, 32(2), 562-565. https://doi.org/10.1038/leu.2017.306